Steven Lichtman
Stock Analyst at William Blair
(4.78)
# 581
Out of 4,988 analysts
1012
Total ratings
52.5%
Success rate
14.5%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFLY Butterfly Network | Reiterated: Buy | n/a | $7.88 | - | 2 | Sep 15, 2026 | |
| BBNX Beta Bionics | Reiterated: Hold | n/a | $21.89 | - | 2 | Sep 14, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | n/a | $21.79 | - | 5 | Sep 14, 2026 | |
| COO The Cooper Companies | Downgraded: Hold | n/a | $55.29 | - | 32 | Sep 12, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $275.12 | - | 54 | Sep 9, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Buy | n/a | $16.87 | - | 44 | Aug 21, 2026 | |
| ENOV Enovis | Reiterated: Buy | n/a | $18.04 | - | 3 | Aug 14, 2026 | |
| SWX: ALC Alcon Inc. | Rated: Hold | n/a | $53.66 | - | 8 | Aug 12, 2026 | |
| OWLT Owlet | Reiterated: Buy | n/a | $4.74 | - | 1 | Aug 12, 2026 | |
| RXST RxSight | Reiterated: Hold | n/a | $5.20 | - | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.02 | - | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $95.36 | - | 73 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $140.60 | - | 65 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $89.35 | - | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $163.81 | - | 16 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $15 | $3.54 | n/a | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $118 | $43.34 | n/a | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7.5 | $13.61 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $78 | $74.08 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $116 | $85.37 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $15.44 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $317.60 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.82 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $94 | $92.13 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.22 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $2.20 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.42 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.76 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.92 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $275.28 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.60 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.897 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7674 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.33 | n/a | 1 | Oct 7, 2011 |
Butterfly Network
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.88
Upside: -
Beta Bionics
Sep 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $21.89
Upside: -
MiniMed Group
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.79
Upside: -
The Cooper Companies
Sep 12, 2026
Downgraded: Hold
Price Target: n/a
Current: $55.29
Upside: -
Stryker
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $275.12
Upside: -
Tandem Diabetes Care
Aug 21, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $16.87
Upside: -
Enovis
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.04
Upside: -
Alcon Inc.
Aug 12, 2026
Rated: Hold
Price Target: n/a
Current: $53.66
Upside: -
Owlet
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.74
Upside: -
RxSight
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.20
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.02
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $95.36
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $140.60
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $89.35
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $163.81
Upside: -
Sep 5, 2025
Reiterated: Buy
Price Target: $12 → $15
Current: $3.54
Upside: n/a
Aug 3, 2025
Reiterated: Hold
Price Target: $118
Current: $43.34
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $11 → $7.5
Current: $13.61
Upside: n/a
May 9, 2025
Reiterated: Hold
Price Target: $73 → $78
Current: $74.08
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $87 → $116
Current: $85.37
Upside: n/a
Jan 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $15.44
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $317.60
Upside: n/a
Nov 1, 2024
Reiterated: Hold
Price Target: n/a
Current: $20.82
Upside: n/a
Aug 21, 2024
Reiterated: Hold
Price Target: $92 → $94
Current: $92.13
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.22
Upside: n/a
Sep 19, 2023
Reiterated: Buy
Price Target: $3.5
Current: $2.20
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $2.76
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $6.92
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $275.28
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.60
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.897
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.7674
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.33
Upside: n/a